BioCentury
ARTICLE | Distillery Therapeutics

Ophthalmic disease

October 10, 2017 8:50 PM UTC

Mouse studies suggest OPN4 gene therapy could help treat end-stage retinal degeneration. In a mouse model of end-stage retinal degeneration, subretinal delivery of an adeno-associated viral serotype 2...

BCIQ Company Profiles

University of Oxford